Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Liver Transplantation

  Free Subscription


Articles published in J Hepatol

Retrieve available abstracts of 74 articles:
HTML format
Text format



Single Articles


    December 2017
  1. VAN VUGT JLA, Alferink LJM, Buettner S, Gaspersz MP, et al
    A Model including Sarcopenia Surpasses the MELD Score in Predicting Waiting List Mortality in Cirrhotic Liver Transplant Candidates.
    J Hepatol. 2017 Dec 5. pii: S0168-8278(17)32474.
    PubMed     Text format     Abstract available


  2. O'GRADY JG
    Relaxing Access to Liver Transplantation with Living Donation: A Foolish Move or a Time to Change?
    J Hepatol. 2017 Dec 2. pii: S0168-8278(17)32477.
    PubMed     Text format    


    November 2017
  3. FAITOT F, Besch C, Battini S, Ruhland E, et al
    Impact of real-time metabolomics in liver transplantation: graft evaluation and donor-recipient matching.
    J Hepatol. 2017 Nov 27. pii: S0168-8278(17)32447.
    PubMed     Text format     Abstract available


  4. KUBILIUN M, Patel SJ, Hur C, Dienstag JL, et al
    Early liver transplantation for alcoholic hepatitis: Ready for primetime?
    J Hepatol. 2017 Nov 23. pii: S0168-8278(17)32452.
    PubMed     Text format    


  5. SCHLEGEL A, Kalisvaart M, Scalera I, Laing RW, et al
    The UK-DCD-Risk-Score: a new proposal to define futility in Donation after Circulatory Death liver transplantation.
    J Hepatol. 2017 Nov 15. pii: S0168-8278(17)32432.
    PubMed     Text format     Abstract available


  6. LINECKER M, Krones T, Berg T, Niemann CU, et al
    Potentially Inappropriate Liver Transplantation in the Era of the "Sickest-first" Policy - A Search for the Upper Limits.
    J Hepatol. 2017 Nov 10. pii: S0168-8278(17)32430.
    PubMed     Text format     Abstract available


    October 2017
  7. CHOUDHARY NS, Saraf N, Soin AS
    Liver Transplantation for Grade 3 Acute on Chronic Liver Failure: Type of Organ Failure is Important.
    J Hepatol. 2017 Oct 31. pii: S0168-8278(17)32401.
    PubMed     Text format    


  8. ARTRU F, Louvet A
    Reply to <<Liver transplantation for grade 3 acute-on-chronic liver failure: type of organ failure is important>>.
    J Hepatol. 2017 Oct 31. pii: S0168-8278(17)32402.
    PubMed     Text format    


  9. LIEBER SR, Schiano TD, Rhodes R
    Should Living Donor Liver Transplantation Be an Option When Deceased Donation Is Not?
    J Hepatol. 2017 Oct 31. pii: S0168-8278(17)32405.
    PubMed     Text format     Abstract available


  10. LONDONO MC, Forns X, Pascasio JM
    Reply to: "Extended DAA indications for hepatitis C patients awaiting liver transplantation and further statistical considerations".
    J Hepatol. 2017 Oct 25. pii: S0168-8278(17)32385.
    PubMed     Text format    


  11. AZAB M, Shah S, Liu X, Ukken J, et al
    Extended DAA indications for hepatitis C patients awaiting liver transplantation and further statistical considerations.
    J Hepatol. 2017 Oct 24. pii: S0168-8278(17)32390.
    PubMed     Text format    


  12. GUSTOT T, Agarwal B
    Selected patients with acute-on-chronic liver failure grade 3 are not too sick to be considered for liver transplantation.
    J Hepatol. 2017;67:667-668.
    PubMed     Text format    


    September 2017
  13. VERHOEVEN CJ, Selten JW, Roest HP, Farid WRR, et al
    Corrigendum to "MicroRNA profiles in graft preservation solution are predictive of ischemic-type biliary lesions after liver transplantation" [J Hepatol 2013; 59:1231-1238].
    J Hepatol. 2017 Sep 27. pii: S0168-8278(17)32279.
    PubMed     Text format    


  14. LIU X, Shen JJ, Jung Kim S, Lee YJ, et al
    Necessity of time series analysis and effects of direct-acting antivirals on HCV patients awaiting liver transplantation.
    J Hepatol. 2017 Sep 19. pii: S0168-8278(17)32290.
    PubMed     Text format    


    August 2017
  15. SAMUEL D, Sanchez-Fueyo A
    Immunotherapy in liver transplantation.
    J Hepatol. 2017 Aug 22. pii: S0168-8278(17)32049.
    PubMed     Text format    


  16. PASCASIO JM, Vinaixa C, Ferrer MT, Colmenero J, et al
    Clinical outcomes of patients undergoing antiviral therapy while awaiting liver transplantation.
    J Hepatol. 2017 Aug 22. pii: S0168-8278(17)32215.
    PubMed     Text format     Abstract available


  17. RAJAKANNU M, Coilly A, Adam R, Samuel D, et al
    Prospective validation of transient elastography for staging liver fibrosis in patients undergoing hepatectomy and liver transplantation.
    J Hepatol. 2017 Aug 21. pii: S0168-8278(17)32214.
    PubMed     Text format    


    July 2017
  18. TRIVEDI PJ, Scalera I, Slaney E, Laing RW, et al
    Clinical outcomes of donation after circulatory death liver transplantation in primary sclerosing cholangitis.
    J Hepatol. 2017 Jul 6. pii: S0168-8278(17)32135.
    PubMed     Text format     Abstract available


    June 2017
  19. ARTRU F, Louvet A, Ruiz I, Levesque E, et al
    Liver transplantation in the most severely ill cirrhotic patients: a multicenter study in acute-on-chronic liver failure grade 3.
    J Hepatol. 2017 Jun 20. pii: S0168-8278(17)32079.
    PubMed     Text format     Abstract available


    May 2017
  20. NADIM MK, DiNorcia J, Ji L, Groshen S, et al
    Inequity In Organ Allocation For Patients Awaiting Liver Transplantation: Rationale for Uncapping the Model for End-Stage Liver Disease.
    J Hepatol. 2017 May 5. pii: S0168-8278(17)32003.
    PubMed     Text format     Abstract available


  21. WENDON, J, Cordoba J, Dhawan A, Larsen FS, et al
    EASL Clinical Practical Guidelines on the management of acute (fulminant) liver failure.
    J Hepatol. 2017;66:1047-1081.
    PubMed     Text format     Abstract available


    April 2017
  22. COLMENERO J, Sancho-Bru P
    Mesenchymal stromal cells for immunomodulatory cell therapy in liver transplantation: one step at a time.
    J Hepatol. 2017 Apr 20. pii: S0168-8278(17)30215.
    PubMed     Text format    


    March 2017
  23. BELLI LS, Duvoux C, Berg T, Strazzabosco M, et al
    ELITA consensus statements on use of DAAs in liver transplant candidates and recipients.
    J Hepatol. 2017 Mar 18. pii: S0168-8278(17)30140.
    PubMed     Text format     Abstract available


  24. DETRY O, Vandermeulen M, Delbouille MH, Somja J, et al
    Infusion of mesenchymal stromal cells after deceased liver transplantation: A phase I-II, open-label, clinical study.
    J Hepatol. 2017 Mar 8. pii: S0168-8278(17)30131.
    PubMed     Text format     Abstract available


    November 2016
  25. NOTARPAOLO A, Layese R, Magistri P, Gambato M, et al
    Validation of the AFP model as a predictor of HCC recurrence in patients with viral hepatitis-related cirrhosis who had received a liver transplant for HCC.
    J Hepatol. 2016 Nov 26. pii: S0168-8278(16)30688.
    PubMed     Text format     Abstract available


    July 2016
  26. PAIS R, Sidney Barritt A 4th, Calmus Y, Scatton O, et al
    Nafld and liver transplantation: current burden and expected challenges.
    J Hepatol. 2016 Jul 30. pii: S0168-8278(16)30403.
    PubMed     Text format     Abstract available


  27. RUF AE, Dirchwolf M, Biggins SW, Villamil FG, et al
    Revising metrics for aggressiveness assessment in liver transplantation centers.
    J Hepatol. 2016 Jul 28. pii: S0168-8278(16)30350.
    PubMed     Text format    


  28. GOLDBERG DS, Abt PL
    Response to Revising Metrics for Aggressiveness Assessment in Liver Transplantation Centers.
    J Hepatol. 2016 Jul 28. pii: S0168-8278(16)30398.
    PubMed     Text format    


  29. YANG JD, Aqel BA, Pungpapong S, Gores GJ, et al
    Direct Acting Antiviral Therapy and Tumor Recurrence after Liver Transplant for Hepatitis C-Associated Hepatocellular Carcinoma.
    J Hepatol. 2016 Jul 5. pii: S0168-8278(16)30318.
    PubMed     Text format    


    June 2016
  30. COILLY A, Fougerou-Leurent C, de Ledinghen V, Houssel-Debry P, et al
    Multicentre experience using daclatasvir and sofosbuvir to treat hepatitis C recurrence after liver transplantation - The CO23 ANRS CUPILT study.
    J Hepatol. 2016 Jun 1. pii: S0168-8278(16)30253.
    PubMed     Text format     Abstract available


    May 2016
  31. BELLI LS, Berenguer M, Cortesi PA, Strazzabosco M, et al
    DELISTING OF LIVER TRANSPLANT CANDIDATES WITH CHRNIC HEPATITIC C AFTER VIRAL ERADICATION: A EUROPEAN STUDY.
    J Hepatol. 2016 May 17. pii: S0168-8278(16)30196.
    PubMed     Text format     Abstract available


  32. SCHLEGEL A, Kron P, de Oliveira ML, Clavien PA, et al
    Reply to 'Is single portal vein perfusion the best approach for machine preservation of liver grafts?'.
    J Hepatol. 2016;64:1195-6.
    PubMed     Text format    


  33. BRUGGENWIRTH IM, Burlage LC, Porte RJ, Martins PN, et al
    Is single portal vein perfusion the best approach for machine preservation of liver grafts?
    J Hepatol. 2016;64:1194-5.
    PubMed     Text format    


    April 2016
  34. WESTBROOK RH, Dusheiko G, Williamson C
    Pregnancy and liver disease.
    J Hepatol. 2016;64:933-45.
    PubMed     Text format     Abstract available


    January 2016
  35. EMOND JC, Zimmer TS
    Measuring access to liver transplantation: an overdue metric for center quality and performance.
    J Hepatol. 2016 Jan 28. pii: S0168-8278(16)00059.
    PubMed     Text format    


  36. SCHLEGEL A, Kron P, De Oliveira ML, Clavien PA, et al
    Is single portal vein approach sufficient for hypothermic machine perfusion of DCD liver grafts?
    J Hepatol. 2016;64:239-41.
    PubMed     Text format    


    November 2015
  37. HONG G, Suh KS, Suh S, Yoo T, et al
    Preoperative Alpha-fetoprotein and F-FDG PET Predict Tumor Recurrence better than Milan Criteria in Living Donor Liver Transplantation.
    J Hepatol. 2015 Nov 30. pii: S0168-8278(15)00791.
    PubMed     Text format     Abstract available


  38. GOLDBERG DS, French B, Lewis JD, Scott FI, et al
    Liver transplant center variability in accepting organ offers and its impact on patient survival.
    J Hepatol. 2015 Nov 25. pii: S0168-8278(15)00773.
    PubMed     Text format     Abstract available



  39. EASL Clinical Practice Guidelines: Liver transplantation.
    J Hepatol. 2015 Nov 17. pii: S0168-8278(15)00677.
    PubMed     Text format    


    September 2015
  40. COILLY A, Samuel D
    Pros and Cons: Usage of organs from donors infected with hepatitis C virus - revision in the direct acting antiviral era.
    J Hepatol. 2015 Sep 12. pii: S0168-8278(15)00617.
    PubMed     Text format     Abstract available


    August 2015
  41. GRANCINI V, Trombetta M, Lunati ME, Zimbalatti D, et al
    Contribution of beta-cell dysfunction and insulin resistance to cirrhosis-associated diabetes: role of severity of liver disease.
    J Hepatol. 2015 Aug 19. pii: S0168-8278(15)00553.
    PubMed     Text format     Abstract available


  42. BOSCH A, Dumortier J, Maucort-Boulch D, Scoazec JY, et al
    Preventive administration of UDCA after liver transplantation for primary biliary cirrhosis is associated with a lower risk of disease recurrence.
    J Hepatol. 2015 Aug 14. pii: S0168-8278(15)00545.
    PubMed     Text format     Abstract available


    July 2015
  43. MILTIADOUS O, Sia D, Hoshida Y, Fiel MI, et al
    Progenitor cell markers predict outcome of patients with Hepatocellular Carcinoma beyond Milan criteria undergoing liver transplantation.
    J Hepatol. 2015 Jul 25. pii: S0168-8278(15)00516.
    PubMed     Text format     Abstract available


  44. TODD STRAVITZ R, Reuben A, Mizrahi M, Lalazar G, et al
    Use of the Methacetin Breath Test to Classify the Risk of Cirrhotic Complications and Mortality in Patients Evaluated/Listed for Liver Transplantation.
    J Hepatol. 2015 Jul 25. pii: S0168-8278(15)00512.
    PubMed     Text format     Abstract available


  45. RAVIKUMAR R, Tsochatzis E, Jose S, Allison M, et al
    Risk Factors for Recurrent Primary Sclerosing Cholangitis After Liver Transplantation.
    J Hepatol. 2015 Jul 14. pii: S0168-8278(15)00467.
    PubMed     Text format     Abstract available


  46. YEOMAN AD, Kotha S, Heneghan MA
    Reply to "The role of corticosteroids in acute-severe autoimmune hepatitis is still highly debatable".
    J Hepatol. 2015 Jul 8. pii: S0168-8278(15)00457.
    PubMed     Text format    


    June 2015
  47. DE MARTIN E, Coilly A, Ichai P, Samuel D, et al
    The role of corticosteroids in acute-severe autoimmune hepatitis is still highly debatable.
    J Hepatol. 2015 Jun 30. pii: S0168-8278(15)00417.
    PubMed     Text format    


  48. KOKUDO T, Hasegawa K, Uldry E, Matsuyama Y, et al
    A new formula for calculating standard liver volume for living donor liver transplantation without using body weight.
    J Hepatol. 2015 Jun 6. pii: S0168-8278(15)00384.
    PubMed     Text format     Abstract available


    April 2015
  49. MATHURIN P, Bataller R
    Trends in the management and burden of alcoholic liver disease.
    J Hepatol. 2015;62.
    PubMed     Text format     Abstract available


  50. ADAMS DH, Sanchez-Fueyo A, Samuel D
    From immunosuppression to tolerance.
    J Hepatol. 2015;62.
    PubMed     Text format     Abstract available


  51. BRUIX J, Han KH, Gores G, Llovet JM, et al
    Liver cancer: Approaching a personalized care.
    J Hepatol. 2015;62.
    PubMed     Text format    


  52. BERNAL W, Lee WM, Wendon J, Larsen FS, et al
    Acute liver failure: A curable disease by 2024?
    J Hepatol. 2015;62.
    PubMed     Text format     Abstract available


  53. MANNS MP, Lohse AW, Vergani D
    Autoimmune hepatitis - Update 2015.
    J Hepatol. 2015;62.
    PubMed     Text format    


    March 2015
  54. KARIMIAN N, Weeder PD, Bomfati F, Gouw AS, et al
    Preservation Injury of the Distal Extrahepatic Bile Duct of Donor Livers Is Representative for Injury of the Intrahepatic Bile Ducts.
    J Hepatol. 2015 Mar 18. pii: S0168-8278(15)00193.
    PubMed     Text format    


  55. SCHLEGEL A, Dutkowski P, Clavien PA
    Reply to: "The rescue of DCD rodent livers grafts: is there HOPE?".
    J Hepatol. 2015;62:739-41.
    PubMed     Text format    


  56. KOPP WH, Wijermars LG, Ringers J, Braat AE, et al
    The rescue of DCD rodent livers grafts: is there HOPE?
    J Hepatol. 2015;62:739.
    PubMed     Text format    


    January 2015
  57. LI H, Xia Q, Zeng B, Li ST, et al
    Submassive hepatic necrosis distinguishes HBV-associated acute-on chronic liver failure from cirrhotic patients with acute decompensation.
    J Hepatol. 2015 Jan 31. pii: S0168-8278(15)00060.
    PubMed     Text format     Abstract available


  58. ALLARD MA, Sebagh M, Ruiz A, Guettier C, et al
    Does Pathological Response for Hepatocellular Carcinoma in Patients with Cirrhosis Predict Outcome after Liver Resection or Transplantation?
    J Hepatol. 2015 Jan 31. pii: S0168-8278(15)00054.
    PubMed     Text format     Abstract available


    December 2014
  59. MUSSO G, Tabibian JH, Charlton M
    Chronic kidney disease (CKD) and NAFLD: time for hepatologists for awareness and screening.
    J Hepatol. 2014 Dec 18. pii: S0168-8278(14)00931.
    PubMed     Text format    


  60. ALLEN AM, Ray Kim W, Heimbach JK, Rule AD, et al
    Reply to: Chronic Kidney Disease (CKD) and NAFLD: time for hepatologists for awareness and screening.
    J Hepatol. 2014 Dec 18. pii: S0168-8278(14)00940.
    PubMed     Text format    


  61. KLUGER MD, Salceda JA, Laurent A, Tayar C, et al
    Liver Resection For Hepatocellular Carcinoma in 313 Western Patients: Tumor Biology and Underlying Liver Rather than Tumor Size Drive Prognosis.
    J Hepatol. 2014 Dec 18. pii: S0168-8278(14)00939.
    PubMed     Text format     Abstract available


    November 2014
  62. LIN LT, Chung CY, Hsu WC, Chang SP, et al
    Saikosaponin b2 is a Naturally Occurring Terpenoid That Efficiently Inhibits Hepatitis C Virus Entry.
    J Hepatol. 2014 Nov 4. pii: S0168-8278(14)00807.
    PubMed     Text format     Abstract available


  63. GAMBATO M, Lens S, Navasa M, Forns X, et al
    Treatment options in patients with decompensated cirrhosis, pre- and post-transplantation.
    J Hepatol. 2014;61.
    PubMed     Text format     Abstract available


    August 2014
  64. JOSHITA S, Umemura T, Ota M, Tanaka E, et al
    AST/platelet ratio index associates with progression to hepatic failure and correlates with histological fibrosis stage in Japanese patients with primary biliary cirrhosis.
    J Hepatol. 2014 Aug 21. pii: S0168-8278(14)00609.
    PubMed     Text format    


  65. TRIVEDI PJ, Bruns T, Li KK, Hirschfield GM, et al
    Reply to: "AST/platelet ratio index associates with progression to hepatic failure and correlates with histological fibrosis stage in Japanese patients with primary biliary cirrhosis"
    J Hepatol. 2014 Aug 21. pii: S0168-8278(14)00606.
    PubMed     Text format    


  66. MOBUS S, Yang D, Yuan Q, Ludtke TH, et al
    MicroRNA-199a-5p inhibition enhances the liver repopulation ability of human embryonic stem cell-derived hepatic cells.
    J Hepatol. 2014 Aug 15. pii: S0168-8278(14)00556.
    PubMed     Text format     Abstract available


  67. SANGFELT P, Sundin A, Wanders A, Rasmussen I, et al
    Monitoring Dominant Strictures in Primary Sclerosing Cholangitis with Brush Cytology and FDG-PET.
    J Hepatol. 2014 Aug 8. pii: S0168-8278(14)00536.
    PubMed     Text format     Abstract available


    July 2014
  68. WEILER-NORMANN C, Lohse AW
    Acute Autoimmune Hepatitis: many open questions.
    J Hepatol. 2014 Jul 3. pii: S0168-8278(14)00460.
    PubMed     Text format    


    May 2014
  69. YEOMAN AD, Westbrook RH, Zen Y, Bernal W, et al
    Prognosis of acute severe autoimmune hepatitis (AS-AIH): The role of corticosteroids in modifying outcome.
    J Hepatol. 2014 May 16. pii: S0168-8278(14)00362.
    PubMed     Text format     Abstract available


    April 2014
  70. DUTKOWSKI P, Schlegel A, de Oliveira M, Mullhaupt B, et al
    HOPE for human liver grafts obtained from donors after cardiac death.
    J Hepatol. 2014;60:765-72.
    PubMed     Text format     Abstract available


    March 2014
  71. KULIK L, Vouche M, Koppe S, Lewandowski RJ, et al
    Prospective Randomized Pilot Study of Y90 +/- Sorafenib as Bridge to Transplantation in Hepatocellular Carcinoma.
    J Hepatol. 2014 Mar 26. pii: S0168-8278(14)00204.
    PubMed     Text format     Abstract available


    January 2014
  72. PERARNAU JM, Gouge AL, Nicolas C, d'Alteroche L, et al
    Covered versus uncovered stents for Transjugular Intrahepatic Portosystemic Shunt: a randomized controlled trial.
    J Hepatol. 2014 Jan 27. pii: S0168-8278(14)00061.
    PubMed     Text format     Abstract available


    December 2013
  73. IRANMANESH P, Vazquez O, Terraz S, Majno P, et al
    Accurate computed tomography-based portal pressure assessment in patients with hepatocellular carcinoma.
    J Hepatol. 2013 Dec 19. pii: S0168-8278(13)00883.
    PubMed     Text format     Abstract available


  74. MATTER MS, Decaens T, Andersen JB, Thorgeirsson SS, et al
    Targeting the mTOR pathway in hepatocellular carcinoma: Current state and future trends.
    J Hepatol. 2013 Dec 2. pii: S0168-8278(13)00833.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Transplantation is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: